CY1115847T1 - Χρηση της τυλβαλοσινης ως αντιϊκο παραγοντα - Google Patents

Χρηση της τυλβαλοσινης ως αντιϊκο παραγοντα

Info

Publication number
CY1115847T1
CY1115847T1 CY20141101098T CY141101098T CY1115847T1 CY 1115847 T1 CY1115847 T1 CY 1115847T1 CY 20141101098 T CY20141101098 T CY 20141101098T CY 141101098 T CY141101098 T CY 141101098T CY 1115847 T1 CY1115847 T1 CY 1115847T1
Authority
CY
Cyprus
Prior art keywords
tylvalosin
antique
factor
tilvalosin
prrsv
Prior art date
Application number
CY20141101098T
Other languages
English (en)
Inventor
Albert Philip Adrian Mockett
Thomas David Kay Brown
Amanda Denise Stuart
Original Assignee
Eco Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0613952A external-priority patent/GB0613952D0/en
Priority claimed from GB0621782A external-priority patent/GB0621782D0/en
Application filed by Eco Animal Health Ltd filed Critical Eco Animal Health Ltd
Publication of CY1115847T1 publication Critical patent/CY1115847T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η εφεύρεση αναφέρεται στη χρήση ενός μακρολιδικού αντιβιοτικού, της τυλβαλοσίνης, ως αντιικό φάρμακο. Η τυλβαλοσίνη είναι ιδιαίτερα χρήσιμη για την αντιμετώπιση του PRRSV.
CY20141101098T 2006-07-13 2014-12-31 Χρηση της τυλβαλοσινης ως αντιϊκο παραγοντα CY1115847T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0613952A GB0613952D0 (en) 2006-07-13 2006-07-13 Antiviral agent
GB0621782A GB0621782D0 (en) 2006-11-01 2006-11-01 Antiviral agent
EP07766205.4A EP2043661B1 (en) 2006-07-13 2007-07-13 Use of tylvalosin as antiviral agent

Publications (1)

Publication Number Publication Date
CY1115847T1 true CY1115847T1 (el) 2017-01-25

Family

ID=38519613

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141101098T CY1115847T1 (el) 2006-07-13 2014-12-31 Χρηση της τυλβαλοσινης ως αντιϊκο παραγοντα

Country Status (15)

Country Link
US (2) US9066964B2 (el)
EP (1) EP2043661B1 (el)
JP (1) JP5232781B2 (el)
KR (1) KR101413274B1 (el)
BR (1) BRPI0714374A2 (el)
CA (1) CA2657275C (el)
CY (1) CY1115847T1 (el)
DK (1) DK2043661T3 (el)
ES (1) ES2526817T3 (el)
MX (1) MX2009000393A (el)
PL (1) PL2043661T3 (el)
PT (1) PT2043661E (el)
RU (1) RU2412710C2 (el)
SI (1) SI2043661T1 (el)
WO (1) WO2008007104A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1021434B1 (nl) 2013-11-20 2015-11-20 Proviron Holding Veevoeder aangerijkt met een combinatie van monoglycerides.
CN103923140B (zh) * 2014-04-14 2016-06-15 宁夏泰瑞制药股份有限公司 一种酒石酸乙酰异戊酰泰乐菌素的制备方法
MX2016014901A (es) 2014-05-13 2017-06-29 Microbial Discovery Group Llc Composiciones microbianas para alimentacion directa y sus metodos de uso.
US10335440B2 (en) 2016-02-29 2019-07-02 Microbial Discovery Group, Llc Direct-fed microbials
CA3114626A1 (en) 2018-09-28 2020-04-02 Microbial Discovery Group, Llc Microorganisms for plant pathogen inhibition
JP2020196704A (ja) * 2019-05-29 2020-12-10 学校法人帝京大学 インフルエンザウイルス感染症またはコロナウイルス感染症の予防および／または治療剤
JP7497790B2 (ja) 2019-12-27 2024-06-11 国立大学法人北海道大学 豚コレラの治療及び／又は予防剤
KR102449133B1 (ko) * 2021-05-10 2022-09-28 전북대학교산학협력단 항바이러스 조성물 및 그의 제조방법
CN115896217A (zh) * 2022-12-16 2023-04-04 内蒙古中牧生物药业有限公司 一种提高泰万菌素发酵水平的补料工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1978409A (en) * 1934-05-01 1934-10-30 Raalte Company Van Mechanism and mechanical method for making runproof or run-re-sistant full-fashionedhosiery
US4092473A (en) * 1975-08-01 1978-05-30 Sanraku Ocean Co., Ltd. Tylosin derivatives and their manufacturing process
GB0025556D0 (en) * 2000-10-18 2000-12-06 Eco Animal Health Ltd Treatment and prophylaxis of disease and infections of pigs and poultry
GB0315629D0 (en) 2003-07-03 2003-08-13 Eco Animal Health Ltd New uses for antibiotic

Also Published As

Publication number Publication date
US9649324B2 (en) 2017-05-16
US9066964B2 (en) 2015-06-30
CA2657275A1 (en) 2008-01-17
KR20100014221A (ko) 2010-02-10
KR101413274B1 (ko) 2014-07-08
WO2008007104A1 (en) 2008-01-17
PL2043661T3 (pl) 2015-03-31
RU2009104022A (ru) 2010-08-20
BRPI0714374A2 (pt) 2013-05-14
SI2043661T1 (sl) 2015-02-27
JP2009542790A (ja) 2009-12-03
US20150313929A1 (en) 2015-11-05
CA2657275C (en) 2013-09-24
JP5232781B2 (ja) 2013-07-10
US20100010080A1 (en) 2010-01-14
MX2009000393A (es) 2009-01-29
DK2043661T3 (en) 2015-01-05
ES2526817T3 (es) 2015-01-15
EP2043661A1 (en) 2009-04-08
EP2043661B1 (en) 2014-10-01
PT2043661E (pt) 2014-12-22
RU2412710C2 (ru) 2011-02-27

Similar Documents

Publication Publication Date Title
CY1115847T1 (el) Χρηση της τυλβαλοσινης ως αντιϊκο παραγοντα
CY1122646T1 (el) Δικυκλικες ετεροαρυλ ενωσεις
CY1119534T1 (el) Παραγωγα φωσφορου ως αναστολεις κινασης
CY1113867T1 (el) Μεθοδος για την παρασκευη ενωσεων που ειναι χρησιμες ως αναστολεις sglt
CY1114793T1 (el) Παραγωγα αμινοπυραζολιου
GB0508318D0 (en) Organic compounds
UY29041A1 (es) Derivados de amino-piperidina, su preparacion y su utilización en terapeutica
UY30057A1 (es) Pirimidinas sustituidas con sulfoximinas, procesos para su producción y uso de las mismas como fármacos
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
ATE445593T1 (de) Acetylenderivate
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
DE602008000754D1 (de) Tropanverbindungen
ECSP077130A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de náuseas y vómitos
BRPI0812222A2 (pt) Compostos ciclobutenodiona substituídos anti-inflamatórios.
JO2734B1 (en) Organic compounds
CY1111954T1 (el) Παραγωγα τετραϋδροναφθαλινιου, μεθοδοι για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδη
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
UY29040A1 (es) Procedimiento de amino-tropano, su preparación y aplicación en terapéutica
CY1111631T1 (el) Παραγωγα των 7-αλκυνυλο-1,8- ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
UY31016A1 (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
NO20091386L (no) Fenyloksyanilinderivater
CY1110787T1 (el) Νεα μορφινικα παραγωγα
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble
UY30237A1 (es) Inhibidores de la adenilato ciclasa soluble
DOP2007000059A (es) Inhibidores de la adenilato ciclasa soluble